Warning: The NCBI web site requires JavaScript to function. more...
Different properties of ACPA and IgM-RF derived from a large dataset: further evidence of two distinct autoantibody systems.
Ursum J, Bos WH, van de Stadt RJ, Dijkmans BA, van Schaardenburg D.
Arthritis Res Ther. 2009;11(3):R75. Epub 2009 May 21.
Related citations
Levels of anti-citrullinated protein antibodies and IgM rheumatoid factor are not associated with outcome in early arthritis patients: a cohort study.
Ursum J, Bos WH, van Dillen N, Dijkmans BA, van Schaardenburg D.
Arthritis Res Ther. 2010;12(1):R8. Epub 2010 Jan 12.
Autoantibody profiling in patients with very early rheumatoid arthritis: a follow-up study.
Nell-Duxneuner V, Machold K, Stamm T, Eberl G, Heinzl H, Hoefler E, Smolen JS, Steiner G.
Ann Rheum Dis. 2010 Jan;69(1):169-74. Epub .
Differential response of the rheumatoid factor and anticitrullinated protein antibodies during adalimumab treatment in patients with rheumatoid arthritis.
Bos WH, Bartelds GM, Wolbink GJ, de Koning MH, van de Stadt RJ, van Schaardenburg D, Dijkmans BA, Nurmohamed MT.
J Rheumatol. 2008 Oct;35(10):1972-7. Epub 2008 Sep 1.
Association of anti-cyclic citrullinated peptide antibodies, anti-citrullin antibodies, and IgM and IgA rheumatoid factors with serological parameters of disease activity in rheumatoid arthritis.
Greiner A, Plischke H, Kellner H, Gruber R.
Ann N Y Acad Sci. 2005 Jun;1050:295-303.
Contribution of PTPN22 1858T, TNFRII 196R and HLA-shared epitope alleles with rheumatoid factor and anti-citrullinated protein antibodies to very early rheumatoid arthritis diagnosis.
Goëb V, Dieudé P, Daveau R, Thomas-L'otellier M, Jouen F, Hau F, Boumier P, Tron F, Gilbert D, Fardellone P, Cornélis F, Le Loët X, Vittecoq O.
Rheumatology (Oxford). 2008 Aug;47(8):1208-12. Epub 2008 Jun 5.
[Cyclic citrullinated peptide antibodies (anti-CCP) together with some other parameters used for serologic diagnosis of rheumatoid arthritis].
Us D, Gülmez D, Hasçelik G.
Mikrobiyol Bul. 2003 Apr-Jun;37(2-3):163-70. Turkish.
Antibodies to porphyromonas gingivalis are associated with anticitrullinated protein antibodies in patients with rheumatoid arthritis and their relatives.
Hitchon CA, Chandad F, Ferucci ED, Willemze A, Ioan-Facsinay A, van der Woude D, Markland J, Robinson D, Elias B, Newkirk M, Toes RM, Huizinga TW, El-Gabalawy HS.
J Rheumatol. 2010 Jun;37(6):1105-12. Epub 2010 May 1.
Predictive value of antibodies to cyclic citrullinated peptide in patients with early arthritis.
Ateş A, Karaaslan Y, Aksaray S.
Clin Rheumatol. 2007 Apr;26(4):499-504. Epub 2006 May 3.
Anti-cyclic citrullinated antibodies: complementary to IgM rheumatoid factor in the early diagnosis of rheumatoid arthritis.
Solanki K, Spellerberg M, Chapman P, Moller P, O'Donnell J.
N Z Med J. 2004 Oct 8;117(1203):U1097.
Are anti-citrulline autoantibodies better serum markers for rheumatoid arthritis than rheumatoid factor in Thai population?
Vanichapuntu M, Phuekfon P, Suwannalai P, Verasertniyom O, Nantiruj K, Janwityanujit S.
Rheumatol Int. 2010 Apr;30(6):755-9. Epub 2009 Jul 12.
Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors.
Nielen MM, van Schaardenburg D, Reesink HW, van de Stadt RJ, van der Horst-Bruinsma IE, de Koning MH, Habibuw MR, Vandenbroucke JP, Dijkmans BA.
Arthritis Rheum. 2004 Feb;50(2):380-6.
Autoantibodies in rheumatoid arthritis: association with severity of disease in established RA.
Agrawal S, Misra R, Aggarwal A.
Clin Rheumatol. 2007 Feb;26(2):201-4. Epub 2006 Mar 30.
Rheumatoid factor and antibodies to cyclic citrullinated Peptide differentiate rheumatoid arthritis from undifferentiated polyarthritis in patients with early arthritis.
Jansen AL, van der Horst-Bruinsma I, van Schaardenburg D, van de Stadt RJ, de Koning MH, Dijkmans BA.
J Rheumatol. 2002 Oct;29(10):2074-6.
Autoantibodies in rheumatoid arthritis: rheumatoid factors and anticitrullinated protein antibodies.
Song YW, Kang EH.
QJM. 2010 Mar;103(3):139-46. Epub 2009 Nov 19. Review.
Marked differences in fine specificity and isotype usage of the anti-citrullinated protein antibody in health and disease.
Ioan-Facsinay A, Willemze A, Robinson DB, Peschken CA, Markland J, van der Woude D, Elias B, Ménard HA, Newkirk M, Fritzler MJ, Toes RE, Huizinga TW, El-Gabalawy HS.
Arthritis Rheum. 2008 Oct;58(10):3000-8.
The value of rheumatoid factor and anti-citrullinated protein antibodies as predictors of response to infliximab in rheumatoid arthritis: an exploratory study.
Klaasen R, Cantaert T, Wijbrandts CA, Teitsma C, Gerlag DM, Out TA, de Nooijer MJ, Baeten D, Tak PP.
Rheumatology (Oxford). 2011 Aug;50(8):1487-93. Epub 2011 Mar 30.
Anti-cyclic citrullinated peptide antibodies, IgM and IgA rheumatoid factors in the diagnosis and prognosis of rheumatoid arthritis.
Bas S, Genevay S, Meyer O, Gabay C.
Rheumatology (Oxford). 2003 May;42(5):677-80.
[Examination of rheumatoid factor and other serum markers in rheumatoid arthritis].
Hiura K, Iwaki-Egawa S, Matsuno H, Watanabe Y.
Yakugaku Zasshi. 2005 Nov;125(11):881-7. Japanese.
Elevated levels of IgM and IgA antibodies to Proteus mirabilis and IgM antibodies to Escherichia coli are associated with early rheumatoid factor (RF)-positive rheumatoid arthritis.
Newkirk MM, Goldbach-Mansky R, Senior BW, Klippel J, Schumacher HR Jr, El-Gabalawy HS.
Rheumatology (Oxford). 2005 Nov;44(11):1433-41. Epub 2005 Aug 9.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on